Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Consensus for the pharmacological management of insomnia in the new millennium
Autore:
Roth, T; Hajak, G; Ustun, TB;
Indirizzi:
Henry Ford Hosp, Sleep Disorders Res Ctr, Detroit, MI 48202 USA Henry FordHosp Detroit MI USA 48202 rders Res Ctr, Detroit, MI 48202 USA Univ Gottingen, Dept Psychiat & Psychotherapy, D-3400 Gottingen, Germany Univ Gottingen Gottingen Germany D-3400 erapy, D-3400 Gottingen, Germany WHO, Assessment Classificat & Epidemiol Grp, CH-1211 Geneva, Switzerland WHO Geneva Switzerland CH-1211 pidemiol Grp, CH-1211 Geneva, Switzerland
Titolo Testata:
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
fascicolo: 1, volume: 55, anno: 2001,
pagine: 42 - 52
SICI:
1368-5031(200101/02)55:1<42:CFTPMO>2.0.ZU;2-U
Fonte:
ISI
Lingua:
ENG
Soggetto:
REBOUND INSOMNIA; POSTMARKETING SURVEILLANCE; BENZODIAZEPINE HYPNOTICS; PSYCHIATRIC-DISORDERS; THERAPEUTIC EFFICACY; SLEEP DISTURBANCE; RISK-FACTORS; ZOLPIDEM; PREVALENCE; WITHDRAWAL;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
116
Recensione:
Indirizzi per estratti:
Indirizzo: Roth, T Henry Ford Hosp, Sleep Disorders Res Ctr, CFP-3,2799 W Grand Blvd,Detroit, MI 48202 USA Henry Ford Hosp CFP-3,2799 W Grand Blvd Detroit MI USA 48202 2 USA
Citazione:
T. Roth et al., "Consensus for the pharmacological management of insomnia in the new millennium", INT J CL PR, 55(1), 2001, pp. 42-52

Abstract

Insomnia, a common symptom throughout the world, is characterised by difficulty initiating or maintaining sleep or non-restorative sleep and is associated with significant morbidity. A comprehensive medical and sleep historyand physical examination are necessary before treating patients with insomnia; the presence of co-morbidities, including medical and psychiatric disorders, or the possible use of substances that may contribute to sleeplessness should be thoroughly investigated. Non-pharmacological approaches include correction of sleep hygiene as well as behavioural treatments. Pharmacotherapy includes benzodiazepine-receptor agonists, which are the drugs of choice for this disorder. They can be subdivided into classic benzodiazepines and non-benzodiazepines. Although many agents in these classes have been prescribed, potential shortcomings include residual sedation, rebound insomnia, and psychomotor and memory impairment, Novel pharmacological strategies that address limitations of the traditional treatment approach, combined with proven modes of behavioural therapy, offer the most successful results in the management of insomnia. These advances provide the opportunity to establish these current recommendations for the optimal management of insomnia. This report from the XXII Collegium Internationale Neuro-Psychopharmacologicum Consensus Workshop outlines recommendations to serve as the foundation for developing a therapeutic plan for each patient.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/20 alle ore 14:44:19